Efficacy News and Research

RSS
Increased viral replication and shedding in nonhuman primates carrying SARS-CoV-2 B.1.1.7 variant

Increased viral replication and shedding in nonhuman primates carrying SARS-CoV-2 B.1.1.7 variant

Rapidly evolving SARS-Cov-2 strains may give rise to escape variants

Rapidly evolving SARS-Cov-2 strains may give rise to escape variants

Two vaccines elicit durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical study

Two vaccines elicit durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical study

COVID-19 Vaccine DSMB can serve as model for future situations

COVID-19 Vaccine DSMB can serve as model for future situations

New web tool offers many capabilities vital to bacteria mutation research

New web tool offers many capabilities vital to bacteria mutation research

UCLA clinical trial shows efficacy of varenicline on heavy-drinking smokers

UCLA clinical trial shows efficacy of varenicline on heavy-drinking smokers

Study may offer an unexpected pathway for targeted treatment of brain tumors

Study may offer an unexpected pathway for targeted treatment of brain tumors

Adapting COVID-19 vaccination strategies based on SARS-CoV-2’s evolution

Adapting COVID-19 vaccination strategies based on SARS-CoV-2’s evolution

RBD and NTD antibody cocktail could prevent the emergence of SARS-CoV-2 escape mutants

RBD and NTD antibody cocktail could prevent the emergence of SARS-CoV-2 escape mutants

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

Researchers screen dual main protease-cathepsin L inhibitors against SARS-CoV-2

Researchers screen dual main protease-cathepsin L inhibitors against SARS-CoV-2

Alkaloids show potential as treatments for COVID-19

Alkaloids show potential as treatments for COVID-19

Treatment-resistant depression relieved by laughing gas

Treatment-resistant depression relieved by laughing gas

SARS-CoV-2 variant of concern could cause further epidemics in UK

SARS-CoV-2 variant of concern could cause further epidemics in UK

Artificial intelligence for predicting TMB-H colorectal cancer from histopathological characteristics

Artificial intelligence for predicting TMB-H colorectal cancer from histopathological characteristics

Cell therapy improves outcomes for heart failure patients, clinical trial shows

Cell therapy improves outcomes for heart failure patients, clinical trial shows

Researchers examine the importance of time after COVID-19 vaccination

Researchers examine the importance of time after COVID-19 vaccination

Robust immunity against SARS-CoV-2 with Pfizer vaccine is mediated by memory B cells

Robust immunity against SARS-CoV-2 with Pfizer vaccine is mediated by memory B cells

Intranasal monoclonal SARS-CoV-2 antibody therapy shows promise in preclinical trials

Intranasal monoclonal SARS-CoV-2 antibody therapy shows promise in preclinical trials

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.